TC BioPharm

Holytown, United Kingdom

TC BioPharm develops safer, cheaper, consistent, and durable CAR-T drugs for hematological and solid tumors.

$250K raised

Nov 2024

Grant

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has TC BioPharm raised?

TC BioPharm has raised $250K in total funding. The most recent round was Grant. The last funding was announced in November 2024.

Who are TC BioPharm's investors?

TC BioPharm's investors include SyndicateRoom, Crowdcube, Genetix Biotherapeutics Inc., Scottish Enterprise, Nipro Corporation.

Where is TC BioPharm headquartered?

TC BioPharm is headquartered in Holytown, United Kingdom.

What does TC BioPharm do?

TC BioPharm develops safer, cheaper, consistent, and durable CAR-T drugs for hematological and solid tumors.

What stage is TC BioPharm at?

TC BioPharm is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 12, 2024.

MLA

"TC BioPharm — Funding & Investors." VCBacked, November 12, 2024, https://www.vcbacked.co/company/tc-biopharm. Accessed July 1, 2026.

APA

VCBacked. (2024). TC BioPharm — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/tc-biopharm

Wikipedia (cite web)

{{cite web |title=TC BioPharm — Funding & Investors |url=https://www.vcbacked.co/company/tc-biopharm |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 12, 2024.